Education
About Us
Working with TipRanks
Follow Us
Bionano Genomics (BNGO)
:BNGO
BNGO Stock Chart & Stats
$1.62
-$0.04(-14.25%)
At close: 4:00 PM EST
$1.62
-$0.04(-14.25%)
Day’s Range― - ―
52-Week Range$1.45 - $22.85
Previous CloseN/A
Volume11.48M
Average Volume (3M)349.25K
Market Cap
$17.10M
Enterprise Value-$5.52M
Total Cash (Recent Filing)$3.06M
Total Debt (Recent Filing)$7.37M
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Mar 05, 2026EPS Estimate
-1.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.04
Shares Outstanding10,176,000
10 Day Avg. Volume351,211
30 Day Avg. Volume349,255
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.93
Price to Sales (P/S)1.07
P/FCF Ratio-0.48
Enterprise Value/Market Cap-0.32
Enterprise Value/Revenue-0.19
Enterprise Value/Gross Profit-0.41
Enterprise Value/Ebitda0.19
Forecast
1Y Price Target
$7.50Price Target Upside362.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenue was $7.4M, representing 21.3% YoY growth and beating our projection of $6.8M.
Reimbursement And RegulatoryThe American Medical Association (AMA) established a second Category I Current Procedural Terminology (CPT) code for the use of OGM, which is key for obtaining reimbursement from third-party payers.
Strategy And AdoptionThe company's strategy focuses on increasing utilization among routine users of optical genome mapping (OGM) and VIA software.
Bears Say
Financial LossNet loss was $8.5M, moderately higher than the estimated loss of $7.8M.
Price ObjectiveDue to an increased amount of shares outstanding, the price objective has decreased to $7.
Revenue GuidanceBionano reiterated 2025 revenue guidance of $26M-$30M, representing a decline from $30.8M in 2024.
BioNano Genomics News
BNGO FAQ
What was Bionano Genomics’s price range in the past 12 months?
Bionano Genomics lowest stock price was $1.45 and its highest was $22.85 in the past 12 months.
What is Bionano Genomics’s market cap?
Bionano Genomics’s market cap is $17.10M.
When is Bionano Genomics’s upcoming earnings report date?
Bionano Genomics’s upcoming earnings report date is Mar 05, 2026 which is in 99 days.
How were Bionano Genomics’s earnings last quarter?
Bionano Genomics released its earnings results on Nov 13, 2025. The company reported -$2.04 earnings per share for the quarter, beating the consensus estimate of -$2.075 by $0.035.
Is Bionano Genomics overvalued?
According to Wall Street analysts Bionano Genomics’s price is currently Undervalued.
Does Bionano Genomics pay dividends?
Bionano Genomics does not currently pay dividends.
What is Bionano Genomics’s EPS estimate?
Bionano Genomics’s EPS estimate is -1.36.
How many shares outstanding does Bionano Genomics have?
Bionano Genomics has 10,176,000 shares outstanding.
What happened to Bionano Genomics’s price movement after its last earnings report?
Bionano Genomics reported an EPS of -$2.04 in its last earnings report, beating expectations of -$2.075. Following the earnings report the stock price went up 3.401%.
Which hedge fund is a major shareholder of Bionano Genomics?
Currently, no hedge funds are holding shares in BNGO
Company Description
Bionano Genomics
BioNano Genomics (BNGO) is a biotechnology company focused on advancing the field of genomics through its innovative solutions for genome mapping and analysis. Operating in the life sciences sector, BNGO specializes in providing tools and technologies that enable researchers and clinicians to better understand genetic variations and their implications in health and disease. The company's core products include the Saphyr system, a platform designed for high-throughput genome mapping, and related consumables and software that facilitate genomic analysis.
BNGO Company Deck
BNGO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, record flow cell sales, and improved gross margins, with significant reductions in operating expenses. However, challenges include limited new system installations and slow market evolution in Japan. Cash reserves are solid, but a portion is restricted.View all BNGO earnings summariesBNGO Stock 12 Month Forecast
Average Price Target
$7.50
▲(362.96% Upside)
Technical Analysis
Ownership Overview
1.97% Insiders
0.31% Mutual Funds
0.43% Other Institutional Investors
96.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---